出版：MarketsandMarkets（マーケッツアンドマーケッツ） 出版年月：2023年6月
収益サイクル管理(RCM)市場 : 製品＆サービス (適格性検証、臨床コーディング、CDI ソリューション、請求処理、拒否管理、アウトソーシングサービス)、配信 (クラウド)、エンドユーザー (支払者、病院) – 2028年までの世界予測
Revenue Cycle Management Market by Product & Services (Eligibility Verification, Clinical Coding, CDI Solutions, Claims Processing, Denial Management, Outsourcing Services), Delivery (Cloud), End Users (Payers, Hospitals) – Global Forecast to 2028
| ページ数 | 320 |
| 図表数 | 336 |
| 種別 | 英文調査報告書 |
| 価格 |
The global revenue cycle management market is projected to reach USD 84.1 billion by 2028 from USD 49.6 billion in 2023, at a CAGR of 11.1% during the forecast period. The RCM market is heavily influenced by evolving regulatory scenarios and coding standards.
There have been constant updates in the ICD 10 Coding System. CMS has introduced 34 new procedure codes into the International Classification of Diseases, which are effective from April 01, 2023. New updates in ICD 10 coding systems subsequently increase dependencies on the automated RCM process, which has positively impacted the RCM market growth. However, emerging countries experience a shortage of skilled employees for operating the newly developed RCM solutions, which might hamper the RCM market growth to a certain extent.
“The outsourcing services segment will grow at the highest rate during the forecast period.”
The revenue cycle management market has been divided into solutions and outsourcing services based on products and services. The revenue cycle management market’s highest share belonged to the outsourcing services category. This segment’s large share and high growth can be attributed to the need for IT infrastructure and the shortage of skilled HCIT personnel.
“By delivery mode, the cloud-based segment accounted for the largest growth rate of revenue cycle management market in 2022.”
The global revenue cycle management market is divided into on-premise and cloud-based segments based on delivery mode. The revenue cycle management market’s cloud-based delivery mode segment accounted for a substantial growth rate. The high growth rate of cloud-based segment can be attributed to the growing availability of highly efficient cloud-based solutions offering easy data transfer within healthcare systems, facilitating clinical and financial workflows.
“By end-user, the healthcare providers segment will grow at the highest rate during the forecast period.”
Healthcare payers and providers are the two segments of the global revenue cycle management market based on end users. The Revenue cycle management market’s highest share belonged to the healthcare providers sector. The significant market share of this sector can be ascribed to the increased demand for automation in all areas, from patient registration to billing and claims processing, and to enhanced transparency that enhances the provider organization’s overall financial health.
“The market in Middle East & Africa is projected to witness the highest growth rate during the forecast period (2021–2028).”
In 2022, the Middle East & Africa market is anticipated to develop at the highest CAGR during the forecast period. Government attempts to encourage eHealth, ever-increasing medical tourism, increased awareness, and the growing need for high-quality healthcare are all responsible for the region’s market’s rapid rise.
A breakdown of the primary participants referred to for this report is provided below:
• By Company Type (Supply-side): Tier 1: 40%, Tier 2: 35%, and Tier 3: 25%
• By Designation: C-level: 25%, Director-level: 55%, and Others: 20%
• By Region: North America: 40%, Asia-Pacific: 25%, Europe: 20%, Latin America: 10%, and Middle East & Africa: 5%
Key Players in the Revenue Cycle Management Market
R1 RCM (US), Oracle (US), Optum (US) are the leading players in the market. Other players include McKesson Corporation (US), Change Healthcare (US), 3M (US), Experian plc (Ireland), Conifer Health Solutions (US), Veradigm (US), GE Healthcare (US), Cognizant (US), athenahealth (US), SSI Group LLC (US), AdvantEdge Healthcare (US), and Huron Consulting Group (US)
Research Coverage:
The report analyzes the revenue cycle management market and aims at estimating the market size and future growth potential of this market based on various segments such as product & services, delivery mode, end user, and region. The report also includes competitive analysis of the key players in this market, their company profiles, products offered, recent developments, and key market strategies.
Reasons to Buy the Report
The report can help established firms as well as new entrants/smaller firms to gauge the pulse of the market, which, in turn, would help them garner a greater share. Firms purchasing the report could use one, or a combination of the below-mentioned five strategies.
This report provides insights into the following pointers:
• Analysis of key drivers (growing regulatory requirements & government initiatives to boost the adoption of RCM Solutions, increasing patient volume and subsequent growth in health insurance, loss of revenue due to billing errors and declining reimbursements, Growing need to manage unstructured healthcare data, rising demand for robust process improvements in healthcare), restraints (IT infrastructural constraints in underdeveloped and developing countries, high deployment costs), opportunities (increasing outsourcing services in developing countries, growing demand for AI & cloud-based deployment), and challenges (issues related to data security and confidentiality, reluctance to switch from conventional methods) influencing the growth of revenue cycle management market (RCM).
• Product Development/Innovation: Detailed insights on upcoming technologies, research and development activities, and product launches in the revenue cycle management market.
• Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the markets for various types of revenue cycle management solutions across regions.
• Market Diversification: Exhaustive information about products, untapped regions, recent developments, and investments in the revenue cycle management market.
• Competitive Assessment: In-depth assessment of market shares, strategies, products, distribution networks, and manufacturing capabilities of the leading players in the revenue cycle management market.
目次
1 INTRODUCTION 39
1.1 STUDY OBJECTIVES 39
1.2 MARKET DEFINITION 39
1.3 MARKET SCOPE 40
1.3.1 INCLUSIONS AND EXCLUSIONS 40
1.3.2 MARKETS COVERED 40
1.3.3 REGIONS COVERED 41
1.3.4 YEARS CONSIDERED 41
1.4 CURRENCY CONSIDERED 41
1.5 STAKEHOLDERS 42
1.6 LIMITATIONS 42
1.7 SUMMARY OF CHANGES 42
1.8 IMPACT OF RECESSION 43
2 RESEARCH METHODOLOGY 44
2.1 RESEARCH DATA 44
FIGURE 1 RESEARCH DESIGN 44
2.1.1 SECONDARY DATA 45
2.1.1.1 Key data from secondary sources 45
2.1.2 PRIMARY DATA 46
FIGURE 2 PRIMARY SOURCES 46
2.1.2.1 Key data from primary sources 47
2.1.2.2 Insights from primary experts 48
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS (SUPPLY SIDE): BY COMPANY TYPE, DESIGNATION, AND REGION 48
2.2 MARKET SIZE ESTIMATION: REVENUE CYCLE MANAGEMENT MARKET 49
FIGURE 4 MARKET SIZE ESTIMATION 50
FIGURE 5 CAGR PROJECTIONS FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 51
FIGURE 6 CAGR PROJECTIONS: OVERALL REVENUE CYCLE MANAGEMENT MARKET 52
2.2.1 TOP-DOWN APPROACH 53
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION 54
FIGURE 7 DATA TRIANGULATION METHODOLOGY 54
2.4 MARKET RANKING ANALYSIS 55
2.5 RESEARCH ASSUMPTIONS 55
2.6 RISK ASSESSMENT 56
TABLE 1 RISK ASSESSMENT: REVENUE CYCLE MANAGEMENT MARKET 56
2.7 RESEARCH LIMITATIONS 56
2.7.1 METHODOLOGY-RELATED LIMITATIONS 56
2.7.2 SCOPE-RELATED LIMITATIONS 56
2.8 IMPACT OF RECESSION ON REVENUE CYCLE MANAGEMENT MARKET 57
3 EXECUTIVE SUMMARY 58
FIGURE 8 REVENUE CYCLE MANAGEMENT MARKET, BY PRODUCT & SERVICE, 2023 VS. 2028 (USD MILLION) 58
FIGURE 9 REVENUE CYCLE MANAGEMENT MARKET, BY DELIVERY MODE, 2023 VS. 2028 (USD MILLION) 59
FIGURE 10 REVENUE CYCLE MANAGEMENT MARKET, BY END USER, 2023 VS. 2028 (USD MILLION) 59
FIGURE 11 NORTH AMERICA ACCOUNTED FOR LARGEST MARKET SHARE IN 2022 60
4 PREMIUM INSIGHTS 61
4.1 ATTRACTIVE OPPORTUNITIES FOR PLAYERS IN REVENUE CYCLE MANAGEMENT MARKET 61
FIGURE 12 GROWING REGULATORY REQUIREMENTS AND GOVERNMENT INITIATIVES TO DRIVE MARKET 61
4.2 REVENUE CYCLE MANAGEMENT MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 62
FIGURE 13 INDIA TO REGISTER HIGHEST GROWTH RATE DURING FORECAST PERIOD 62
4.3 REGIONAL MIX: REVENUE CYCLE MANAGEMENT MARKET (2021–2028) 63
FIGURE 14 MIDDLE EAST & AFRICA TO REGISTER HIGHEST GROWTH RATE DURING FORECAST PERIOD 63
4.4 REVENUE CYCLE MANAGEMENT MARKET: DEVELOPED VS. EMERGING ECONOMIES, 2023 VS. 2028 (USD MILLION) 63
FIGURE 15 DEVELOPING MARKETS TO REGISTER HIGHER GROWTH DURING FORECAST PERIOD 63
5 MARKET OVERVIEW 64
5.1 INTRODUCTION 64
5.2 MARKET DYNAMICS 64
TABLE 2 REVENUE CYCLE MANAGEMENT MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 64
5.2.1 DRIVERS 65
5.2.1.1 Growing regulatory requirements and government initiatives 65
5.2.1.2 Increasing patient volume and subsequent growth in health insurance 66
5.2.1.3 Loss of revenue due to billing errors and declining reimbursements 66
5.2.1.4 Growing need to manage unstructured healthcare data 67
5.2.1.5 Rising demand for robust process improvements in healthcare sector 67
5.2.2 RESTRAINTS 68
5.2.2.1 High deployment costs 68
5.2.2.2 IT infrastructural constraints in emerging economies 68
5.2.3 OPPORTUNITIES 69
5.2.3.1 Increasing outsourcing services in emerging economies 69
5.2.3.2 Growing demand for AI and cloud-based deployment 70
5.2.4 CHALLENGES 71
5.2.4.1 Issues related to data security and confidentiality 71
5.2.4.2 Reluctance to switch from conventional methods 71
6 INDUSTRY TRENDS 72
6.1 GREATER FOCUS ON PATIENT FINANCIAL EXPERIENCE 72
6.2 USE OF ARTIFICIAL INTELLIGENCE AND MACHINE LEARNING 72
6.3 PIVOTAL ROLE OF DATA ANALYSIS IN MANAGING HEALTHCARE REVENUE CYCLES 72
6.4 INCREASING NUMBER OF PARTNERSHIPS AND COLLABORATIONS TO DRIVE INNOVATION 73
6.4.1 TECHNOLOGY ANALYSIS 73
6.5 PORTER’S FIVE FORCES ANALYSIS 74
FIGURE 16 REVENUE CYCLE MANAGEMENT MARKET: PORTER’S FIVE FORCES ANALYSIS 75
TABLE 3 REVENUE CYCLE MANAGEMENT MARKET: PORTER’S FIVE FORCES ANALYSIS 75
6.5.1 INTENSITY OF COMPETITIVE RIVALRY 76
6.5.2 BARGAINING POWER OF SUPPLIERS 76
6.5.3 BARGAINING POWER OF BUYERS 76
6.5.4 THREAT OF NEW ENTRANTS 76
6.5.5 THREAT OF SUBSTITUTES 76
6.6 REGULATORY LANDSCAPE 77
6.6.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 77
TABLE 4 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 77
TABLE 5 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 78
TABLE 6 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 79
TABLE 7 REST OF THE WORLD: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 79
TABLE 8 REVENUE CYCLE MANAGEMENT MARKET: REGULATORY STANDARDS 80
6.7 VALUE CHAIN ANALYSIS 80
FIGURE 17 VALUE CHAIN ANALYSIS (2022) 81
6.8 ECOSYSTEM/MARKET MAP 81
FIGURE 18 REVENUE CYCLE MANAGEMENT MARKET: ECOSYSTEM 81
6.9 PATENT ANALYSIS 82
FIGURE 19 NUMBER OF PATENTS PUBLISHED, JANUARY 2013 TO JUNE 2023 82
FIGURE 20 TOP REVENUE CYCLE MANAGEMENT PATENT OWNERS 82
TABLE 9 KEY PATENTS IN REVENUE CYCLE MANAGEMENT MARKET (2020–2023) 83
6.10 ADJACENT MARKET ANALYSIS 84
FIGURE 21 POPULATION HEALTH MANAGEMENT MARKET: MARKET OVERVIEW 84
FIGURE 22 HEALTHCARE ANALYTICS MARKET: MARKET OVERVIEW 85
6.11 CASE STUDY ANALYSIS 85
6.12 KEY STAKEHOLDERS AND BUYING CRITERIA 86
6.12.1 KEY STAKEHOLDERS IN BUYING PROCESS 86
FIGURE 23 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS 86
TABLE 10 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS (%) 87
6.12.2 BUYING CRITERIA 87
FIGURE 24 KEY BUYING CRITERIA FOR REVENUE CYCLE MANAGEMENT COMPONENTS 87
TABLE 11 KEY BUYING CRITERIA FOR REVENUE CYCLE MANAGEMENT COMPONENTS 87
6.13 KEY CONFERENCES AND EVENTS IN 2023–2024 88
TABLE 12 REVENUE CYCLE MANAGEMENT MARKET: DETAILED LIST OF CONFERENCES AND EVENTS 88
6.14 PRICING ANALYSIS 88
6.15 TRENDS/DISRUPTIONS IMPACTING BUYERS 89
FIGURE 25 REVENUE CYCLE MANAGEMENT MARKET: TRENDS/DISRUPTIONS IMPACTING BUYERS 89
7 REVENUE CYCLE MANAGEMENT MARKET, BY PRODUCT & SERVICE 90
7.1 INTRODUCTION 91
TABLE 13 REVENUE CYCLE MANAGEMENT MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 91
7.2 SOLUTIONS 91
TABLE 14 SOLUTIONS OFFERED BY KEY MARKET PLAYERS 92
TABLE 15 SOLUTIONS: REVENUE CYCLE MANAGEMENT MARKET, BY TYPE, 2021–2028 (USD MILLION) 92
7.2.1 PATIENT ACCESS SOLUTIONS 93
TABLE 16 PATIENT ACCESS SOLUTIONS MARKET, BY TYPE, 2021–2028 (USD MILLION) 93
TABLE 17 PATIENT ACCESS SOLUTIONS MARKET, BY COUNTRY/REGION, 2021–2028 (USD MILLION) 94
7.2.1.1 Eligibility verification solutions 94
7.2.1.1.1 Eligibility verification solutions segment to account for largest share of patient access solutions market 94
TABLE 18 ELIGIBILITY VERIFICATION SOLUTIONS OFFERED BY KEY MARKET PLAYERS 95
TABLE 19 ELIGIBILITY VERIFICATION SOLUTIONS MARKET, BY COUNTRY/REGION, 2021–2028 (USD MILLION) 96
7.2.1.2 Pre-certification & authorization solutions 96
7.2.1.2.1 Electronic pre-certification and authorization help reduce error risks 96
TABLE 20 PRE-CERTIFICATION & AUTHORIZATION SOLUTIONS OFFERED BY KEY MARKET PLAYERS 97
TABLE 21 PRE-CERTIFICATION & AUTHORIZATION SOLUTIONS MARKET, BY COUNTRY/REGION, 2021–2028 (USD MILLION) 97
7.2.1.3 Other patient access solutions 98
TABLE 22 OTHER PATIENT ACCESS SOLUTIONS OFFERED BY KEY MARKET PLAYERS 98
TABLE 23 OTHER PATIENT ACCESS SOLUTIONS MARKET, BY COUNTRY/REGION, 2021–2028 (USD MILLION) 99
7.2.2 MID-REVENUE CYCLE SOLUTIONS 99
TABLE 24 MID-REVENUE CYCLE SOLUTIONS MARKET, BY TYPE, 2021–2028 (USD MILLION) 100
TABLE 25 MID-REVENUE CYCLE SOLUTIONS MARKET, BY COUNTRY/REGION, 2021–2028 (USD MILLION) 100
7.2.2.1 Clinical coding solutions 101
7.2.2.1.1 Increasing complexity of medical codes to drive market 101
TABLE 26 CLINICAL CODING SOLUTIONS OFFERED BY KEY MARKET PLAYERS 101
TABLE 27 CLINICAL CODING SOLUTIONS MARKET, BY COUNTRY/REGION, 2021–2028 (USD MILLION) 102
7.2.2.2 Clinical documentation improvement solutions 102
7.2.2.2.1 Automated feedback and guidance by CDI solutions help physicians improve accuracy of patient records 102
TABLE 28 CLINICAL DOCUMENTATION IMPROVEMENT SOLUTIONS OFFERED BY KEY MARKET PLAYERS 103
TABLE 29 CLINICAL DOCUMENTATION IMPROVEMENT SOLUTIONS MARKET, BY COUNTRY/ REGION, 2021–2028 (USD MILLION) 103
7.2.2.3 Other mid-revenue cycle solutions 104
TABLE 30 OTHER MID-REVENUE CYCLE SOLUTIONS OFFERED BY KEY MARKET PLAYERS 104
TABLE 31 OTHER MID-REVENUE CYCLE SOLUTIONS MARKET, BY COUNTRY/REGION, 2021–2028 (USD MILLION) 104
7.2.3 BACK-END REVENUE CYCLE SOLUTIONS 105
TABLE 32 BACK-END REVENUE CYCLE SOLUTIONS MARKET, BY TYPE, 2021–2028 (USD MILLION) 105
TABLE 33 BACK-END REVENUE CYCLE SOLUTIONS MARKET, BY COUNTRY/REGION, 2021–2028 (USD MILLION) 106
7.2.3.1 Claims processing solutions 106
7.2.3.1.1 Claims processing solutions help reduce false claims and manual effort 106
TABLE 34 CLAIMS PROCESSING SOLUTIONS OFFERED BY KEY MARKET PLAYERS 107
TABLE 35 CLAIMS PROCESSING SOLUTIONS MARKET, BY COUNTRY/REGION, 2021–2028 (USD MILLION) 107
7.2.3.2 Denial management solutions 108
7.2.3.2.1 Denial management solutions help healthcare payers and providers with effective claims management 108
TABLE 36 DENIAL MANAGEMENT SOLUTIONS OFFERED BY KEY MARKET PLAYERS 108
TABLE 37 DENIAL MANAGEMENT SOLUTIONS MARKET, BY COUNTRY/REGION, 2021–2028 (USD MILLION) 109
7.2.3.3 Other back-end revenue cycle solutions 109
TABLE 38 OTHER BACK-END REVENUE CYCLE SOLUTIONS OFFERED BY KEY MARKET PLAYERS 109
TABLE 39 OTHER BACK-END REVENUE CYCLE SOLUTIONS MARKET, BY COUNTRY/REGION, 2021–2028 (USD MILLION) 110
7.3 OUTSOURCING SERVICES 111
TABLE 40 OUTSOURCING SERVICES: REVENUE CYCLE MANAGEMENT MARKET, BY TYPE, 2021–2028 (USD MILLION) 111
TABLE 41 OUTSOURCING SERVICES: REVENUE CYCLE MANAGEMENT MARKET, BY COUNTRY/REGION, 2021–2028(USD MILLION) 112
7.3.1 PATIENT ACCESS OUTSOURCING SERVICES 112
7.3.1.1 Patient access outsourcing services segment to account for largest share of outsourcing services market 112
TABLE 42 PATIENT ACCESS OUTSOURCING SERVICES OFFERED BY KEY MARKET PLAYERS 113
TABLE 43 PATIENT ACCESS OUTSOURCING SERVICES MARKET, BY COUNTRY/REGION, 2021–2028 (USD MILLION) 114
7.3.2 MID-REVENUE CYCLE OUTSOURCING SERVICES 114
7.3.2.1 Increasing losses due to billing errors, scarcity of IT professionals, and infrastructure limitations to drive market 114
TABLE 44 MID-REVENUE CYCLE OUTSOURCING SERVICES OFFERED BY KEY MARKET PLAYERS 115
TABLE 45 MID-REVENUE CYCLE OUTSOURCING SERVICES MARKET, BY COUNTRY/REGION, 2021–2028 (USD MILLION) 115
7.3.3 BACK-END REVENUE CYCLE OUTSOURCING SERVICES 116
7.3.3.1 Shortage of skilled HCIT professionals to drive market 116
TABLE 46 BACK-END REVENUE CYCLE OUTSOURCING SERVICES OFFERED BY KEY MARKET PLAYERS 116
TABLE 47 BACK-END REVENUE CYCLE OUTSOURCING SERVICES MARKET, BY COUNTRY/REGION, 2021–2028 (USD MILLION) 117
8 REVENUE CYCLE MANAGEMENT MARKET, BY DELIVERY MODE 118
8.1 INTRODUCTION 119
TABLE 48 REVENUE CYCLE MANAGEMENT MARKET, BY DELIVERY MODE, 2021–2028 (USD MILLION) 119
8.2 ON-PREMISES SOLUTIONS 119
8.2.1 ABILITY TO REUSE EXISTING SERVERS AND STORAGE HARDWARE TO DRIVE DEMAND FOR ON-PREMISES SOLUTIONS 119
TABLE 49 ON-PREMISES SOLUTIONS: REVENUE CYCLE MANAGEMENT MARKET, BY COUNTRY/REGION, 2021–2028 (USD MILLION) 120
8.3 CLOUD-BASED SOLUTIONS 120
8.3.1 DEMAND FOR AFFORDABLE CLOUD-BASED REVENUE CYCLE MANAGEMENT SOLUTIONS FROM SMALL AND MEDIUM-SIZED HEALTHCARE FACILITIES TO DRIVE MARKET 120
TABLE 50 CLOUD-BASED SOLUTIONS: REVENUE CYCLE MANAGEMENT MARKET, BY COUNTRY/REGION, 2021–2028 (USD MILLION) 121
9 REVENUE CYCLE MANAGEMENT MARKET, BY END USER 122
9.1 INTRODUCTION 123
TABLE 51 REVENUE CYCLE MANAGEMENT MARKET, BY END USER, 2021–2028 (USD MILLION) 123
9.2 HEALTHCARE PROVIDERS 123
TABLE 52 REVENUE CYCLE MANAGEMENT MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2021–2028 (USD MILLION) 124
TABLE 53 REVENUE CYCLE MANAGEMENT MARKET FOR HEALTHCARE PROVIDERS, BY COUNTRY/REGION, 2021–2028 (USD MILLION) 124
9.2.1 INPATIENT FACILITIES 125
TABLE 54 REVENUE CYCLE MANAGEMENT MARKET FOR INPATIENT FACILITIES, BY TYPE, 2021–2028 (USD MILLION) 125
TABLE 55 REVENUE CYCLE MANAGEMENT MARKET FOR INPATIENT FACILITIES, BY COUNTRY/REGION, 2021–2028 (USD MILLION) 126
9.2.1.1 Hospitals 126
9.2.1.1.1 Growing need to improve profitability in healthcare operations to drive adoption of RCM tools in hospitals 126
TABLE 56 REVENUE CYCLE MANAGEMENT MARKET FOR HOSPITALS, BY COUNTRY/REGION, 2021–2028 (USD MILLION) 127
9.2.1.2 Other inpatient facilities 127
TABLE 57 REVENUE CYCLE MANAGEMENT MARKET FOR OTHER INPATIENT FACILITIES, BY COUNTRY/REGION, 2021–2028 (USD MILLION) 128
9.2.2 OUTPATIENT FACILITIES 128
TABLE 58 REVENUE CYCLE MANAGEMENT MARKET FOR OUTPATIENT FACILITIES, BY TYPE, 2021–2028 (USD MILLION) 129
TABLE 59 REVENUE CYCLE MANAGEMENT MARKET FOR OUTPATIENT FACILITIES, BY COUNTRY/REGION, 2021–2028 (USD MILLION) 129
9.2.2.1 Physician practices 130
9.2.2.1.1 High demand for integration of EHR with practice management systems among physician practices 130
TABLE 60 REVENUE CYCLE MANAGEMENT MARKET FOR PHYSICIAN PRACTICES, BY COUNTRY/REGION, 2021–2028 (USD MILLION) 130
9.2.2.2 Ambulatory surgical centers (ASCs) 131
9.2.2.2.1 Eroding patient volumes at hospitals due to high infection rate of COVID-19 to drive demand for ASCs 131
TABLE 61 REVENUE CYCLE MANAGEMENT MARKET FOR AMBULATORY SURGICAL CENTERS, BY COUNTRY/REGION, 2021–2028 (USD MILLION) 131
9.2.2.3 Hospital outpatient facilities 132
9.2.2.3.1 Need to maintain documentation for high volume of patients in hospital OPDs to drive demand for RCM solutions 132
TABLE 62 REVENUE CYCLE MANAGEMENT MARKET FOR HOSPITAL OUTPATIENT FACILITIES, BY COUNTRY/REGION, 2021–2028 (USD MILLION) 132
9.2.2.4 Diagnostic & imaging centers 133
9.2.2.4.1 Growing preference of patients for shorter waiting times & technologically advanced specialty clinics to drive demand for diagnostic & imaging centers 133
TABLE 63 REVENUE CYCLE MANAGEMENT MARKET FOR DIAGNOSTIC & IMAGING CENTERS, BY COUNTRY/REGION, 2021–2028 (USD MILLION) 133
9.2.2.5 Other outpatient facilities 134
TABLE 64 REVENUE CYCLE MANAGEMENT MARKET FOR OTHER OUTPATIENT FACILITIES, BY COUNTRY/REGION, 2021–2028 (USD MILLION) 134
9.3 HEALTHCARE PAYERS 135
9.3.1 INCREASING PRODUCTIVITY AND PROFITABILITY OF CODING OPERATIONS TO DRIVE ADOPTION OF RCM SOLUTIONS BY HEALTHCARE PAYERS 135
TABLE 65 REVENUE CYCLE MANAGEMENT MARKET FOR HEALTHCARE PAYERS, BY COUNTRY/REGION, 2021–2028 (USD MILLION) 135
10 REVENUE CYCLE MANAGEMENT MARKET, BY REGION 136
10.1 INTRODUCTION 137
TABLE 66 REVENUE CYCLE MANAGEMENT MARKET, BY REGION, 2021–2028 (USD MILLION) 137
10.2 NORTH AMERICA 137
FIGURE 26 NORTH AMERICA: REVENUE CYCLE MANAGEMENT MARKET SNAPSHOT 138
TABLE 67 NORTH AMERICA: REVENUE CYCLE MANAGEMENT MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 139
TABLE 68 NORTH AMERICA: REVENUE CYCLE MANAGEMENT MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 139
TABLE 69 NORTH AMERICA: REVENUE CYCLE MANAGEMENT SOLUTIONS MARKET, BY TYPE, 2021–2028 (USD MILLION) 140
TABLE 70 NORTH AMERICA: PATIENT ACCESS SOLUTIONS MARKET, BY TYPE, 2021–2028 (USD MILLION) 140
TABLE 71 NORTH AMERICA: MID-REVENUE CYCLE SOLUTIONS MARKET, BY TYPE, 2021–2028 (USD MILLION) 141
TABLE 72 NORTH AMERICA: BACK-END REVENUE CYCLE SOLUTIONS MARKET, BY TYPE, 2021–2028 (USD MILLION) 141
TABLE 73 NORTH AMERICA: REVENUE CYCLE OUTSOURCING SERVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 142
TABLE 74 NORTH AMERICA: REVENUE CYCLE MANAGEMENT MARKET, BY DELIVERY MODE, 2021–2028 (USD MILLION) 142
TABLE 75 NORTH AMERICA: REVENUE CYCLE MANAGEMENT MARKET, BY END USER, 2021–2028 (USD MILLION) 143
TABLE 76 NORTH AMERICA: REVENUE CYCLE MANAGEMENT MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2021–2028 (USD MILLION) 143
TABLE 77 NORTH AMERICA: REVENUE CYCLE MANAGEMENT MARKET FOR INPATIENT FACILITIES, BY TYPE, 2021–2028 (USD MILLION) 143
TABLE 78 NORTH AMERICA: REVENUE CYCLE MANAGEMENT MARKET FOR OUTPATIENT FACILITIES, BY TYPE, 2021–2028 (USD MILLION) 144
10.2.1 US 144
10.2.1.1 Growing focus of healthcare providers on improving care quality and reducing medical errors & healthcare expenses to drive market 144
TABLE 79 US: KEY MACRO INDICATORS 145
TABLE 80 US: REVENUE CYCLE MANAGEMENT MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 145
TABLE 81 US: REVENUE CYCLE MANAGEMENT SOLUTIONS MARKET, BY TYPE, 2021–2028 (USD MILLION) 146
TABLE 82 US: PATIENT ACCESS SOLUTIONS MARKET, BY TYPE, 2021–2028 (USD MILLION) 146
TABLE 83 US: MID-REVENUE CYCLE SOLUTIONS MARKET, BY TYPE, 2021–2028 (USD MILLION) 147
TABLE 84 US: BACK-END REVENUE CYCLE SOLUTIONS MARKET, BY TYPE, 2021–2028 (USD MILLION) 147
TABLE 85 US: REVENUE CYCLE OUTSOURCING SERVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 148
TABLE 86 US: REVENUE CYCLE MANAGEMENT MARKET, BY DELIVERY MODE, 2021–2028 (USD MILLION) 148
TABLE 87 US: REVENUE CYCLE MANAGEMENT MARKET, BY END USER, 2021–2028 (USD MILLION) 149
TABLE 88 US: REVENUE CYCLE MANAGEMENT MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2021–2028 (USD MILLION) 149
TABLE 89 US: REVENUE CYCLE MANAGEMENT MARKET FOR INPATIENT FACILITIES, BY TYPE, 2021–2028 (USD MILLION) 149
TABLE 90 US: REVENUE CYCLE MANAGEMENT MARKET FOR OUTPATIENT FACILITIES, BY TYPE, 2021–2028 (USD MILLION) 150
10.2.2 CANADA 150
10.2.2.1 Need for healthcare cost containment and financial management of healthcare organizations to support market growth 150
TABLE 91 CANADA: KEY MACRO INDICATORS 151
TABLE 92 CANADA: REVENUE CYCLE MANAGEMENT MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 151
TABLE 93 CANADA: REVENUE CYCLE MANAGEMENT SOLUTIONS MARKET, BY TYPE, 2021–2028 (USD MILLION) 151
TABLE 94 CANADA: PATIENT ACCESS SOLUTIONS MARKET, BY TYPE, 2021–2028 (USD MILLION) 152
TABLE 95 CANADA: MID-REVENUE CYCLE SOLUTIONS MARKET, BY TYPE, 2021–2028 (USD MILLION) 152
TABLE 96 CANADA: BACK-END REVENUE CYCLE SOLUTIONS MARKET, BY TYPE, 2021–2028 (USD MILLION) 153
TABLE 97 CANADA: REVENUE CYCLE OUTSOURCING SERVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 153
TABLE 98 CANADA: REVENUE CYCLE MANAGEMENT MARKET, BY DELIVERY MODE, 2021–2028 (USD MILLION) 154
TABLE 99 CANADA: REVENUE CYCLE MANAGEMENT MARKET, BY END USER, 2021–2028 (USD MILLION) 154
TABLE 100 CANADA: REVENUE CYCLE MANAGEMENT MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2021–2028 (USD MILLION) 154
TABLE 101 CANADA: REVENUE CYCLE MANAGEMENT MARKET FOR INPATIENT FACILITIES, BY TYPE, 2021–2028 (USD MILLION) 155
TABLE 102 CANADA: REVENUE CYCLE MANAGEMENT MARKET FOR OUTPATIENT FACILITIES, BY TYPE, 2021–2028 (USD MILLION) 155
10.3 EUROPE 155
TABLE 103 EUROPE: REVENUE CYCLE MANAGEMENT MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 156
TABLE 104 EUROPE: REVENUE CYCLE MANAGEMENT MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 157
TABLE 105 EUROPE: REVENUE CYCLE MANAGEMENT SOLUTIONS MARKET, BY TYPE, 2021–2028 (USD MILLION) 157
TABLE 106 EUROPE: PATIENT ACCESS SOLUTIONS MARKET, BY TYPE, 2021–2028 (USD MILLION) 158
TABLE 107 EUROPE: MID-REVENUE CYCLE SOLUTIONS MARKET, BY TYPE, 2021–2028 (USD MILLION) 158
TABLE 108 EUROPE: BACK-END REVENUE CYCLE SOLUTIONS MARKET, BY TYPE, 2021–2028 (USD MILLION) 159
TABLE 109 EUROPE: REVENUE CYCLE OUTSOURCING SERVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 159
TABLE 110 EUROPE: REVENUE CYCLE MANAGEMENT MARKET, BY DELIVERY MODE, 2021–2028 (USD MILLION) 160
TABLE 111 EUROPE: REVENUE CYCLE MANAGEMENT MARKET, BY END USER, 2021–2028 (USD MILLION) 160
TABLE 112 EUROPE: REVENUE CYCLE MANAGEMENT MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2021–2028 (USD MILLION) 160
TABLE 113 EUROPE: REVENUE CYCLE MANAGEMENT MARKET FOR INPATIENT FACILITIES, BY TYPE, 2021–2028 (USD MILLION) 161
TABLE 114 EUROPE: REVENUE CYCLE MANAGEMENT MARKET FOR OUTPATIENT FACILITIES, BY TYPE, 2021–2028 (USD MILLION) 161
10.3.1 GERMANY 161
10.3.1.1 Increasing patient volume to boost adoption of RCM solutions 161
TABLE 115 GERMANY: KEY MACRO INDICATORS 162
TABLE 116 GERMANY: REVENUE CYCLE MANAGEMENT MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 162
TABLE 117 GERMANY: REVENUE CYCLE MANAGEMENT SOLUTIONS MARKET, BY TYPE, 2021–2028 (USD MILLION) 163
TABLE 118 GERMANY: PATIENT ACCESS SOLUTIONS MARKET, BY TYPE, 2021–2028 (USD MILLION) 163
TABLE 119 GERMANY: MID-REVENUE CYCLE SOLUTIONS MARKET, BY TYPE, 2021–2028 (USD MILLION) 164
TABLE 120 GERMANY: BACK-END REVENUE CYCLE SOLUTIONS MARKET, BY TYPE, 2021–2028 (USD MILLION) 164
TABLE 121 GERMANY: REVENUE CYCLE OUTSOURCING SERVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 165
TABLE 122 GERMANY: REVENUE CYCLE MANAGEMENT MARKET, BY DELIVERY MODE, 2021–2028 (USD MILLION) 165
TABLE 123 GERMANY: REVENUE CYCLE MANAGEMENT MARKET, BY END USER, 2021–2028 (USD MILLION) 165
TABLE 124 GERMANY: REVENUE CYCLE MANAGEMENT MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2021–2028 (USD MILLION) 166
TABLE 125 GERMANY: REVENUE CYCLE MANAGEMENT MARKET FOR INPATIENT FACILITIES, BY TYPE, 2021–2028 (USD MILLION) 166
TABLE 126 GERMANY: REVENUE CYCLE MANAGEMENT MARKET FOR OUTPATIENT FACILITIES, BY TYPE, 2021–2028 (USD MILLION) 167
10.3.2 FRANCE 167
10.3.2.1 Government investments to increase demand for effective RCM solutions 167
TABLE 127 FRANCE: KEY MACRO INDICATORS 168
TABLE 128 FRANCE: REVENUE CYCLE MANAGEMENT MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 168
TABLE 129 FRANCE: REVENUE CYCLE MANAGEMENT SOLUTIONS MARKET, BY TYPE, 2021–2028 (USD MILLION) 168
TABLE 130 FRANCE: PATIENT ACCESS SOLUTIONS MARKET, BY TYPE, 2021–2028 (USD MILLION) 169
TABLE 131 FRANCE: MID-REVENUE CYCLE SOLUTIONS MARKET, BY TYPE, 2021–2028 (USD MILLION) 169
TABLE 132 FRANCE: BACK-END REVENUE CYCLE SOLUTIONS MARKET, BY TYPE, 2021–2028 (USD MILLION) 170
TABLE 133 FRANCE: REVENUE CYCLE OUTSOURCING SERVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 170
TABLE 134 FRANCE: REVENUE CYCLE MANAGEMENT MARKET, BY DELIVERY MODE, 2021–2028 (USD MILLION) 171
TABLE 135 FRANCE: REVENUE CYCLE MANAGEMENT MARKET, BY END USER, 2021–2028 (USD MILLION) 171
TABLE 136 FRANCE: REVENUE CYCLE MANAGEMENT MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2021–2028 (USD MILLION) 171
TABLE 137 FRANCE: REVENUE CYCLE MANAGEMENT MARKET FOR INPATIENT FACILITIES, BY TYPE, 2021–2028 (USD MILLION) 172
TABLE 138 FRANCE: REVENUE CYCLE MANAGEMENT MARKET FOR OUTPATIENT FACILITIES, BY TYPE, 2021–2028 (USD MILLION) 172
10.3.3 UK 172
10.3.3.1 Growing patient pool to boost demand for RCM solutions & services 172
TABLE 139 UK: KEY MACRO INDICATORS 173
TABLE 140 UK: REVENUE CYCLE MANAGEMENT MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 173
TABLE 141 UK: REVENUE CYCLE MANAGEMENT SOLUTIONS MARKET, BY TYPE, 2021–2028 (USD MILLION) 174
TABLE 142 UK: PATIENT ACCESS SOLUTIONS MARKET, BY TYPE, 2021–2028 (USD MILLION) 174
TABLE 143 UK: MID-REVENUE CYCLE SOLUTIONS MARKET, BY TYPE, 2021–2028 (USD MILLION) 175
TABLE 144 UK: BACK-END REVENUE CYCLE SOLUTIONS MARKET, BY TYPE, 2021–2028 (USD MILLION) 175
TABLE 145 UK: REVENUE CYCLE OUTSOURCING SERVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 176
TABLE 146 UK: REVENUE CYCLE MANAGEMENT MARKET, BY DELIVERY MODE, 2021–2028 (USD MILLION) 176
TABLE 147 UK: REVENUE CYCLE MANAGEMENT MARKET, BY END USER, 2021–2028 (USD MILLION) 176
TABLE 148 UK: REVENUE CYCLE MANAGEMENT MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2021–2028 (USD MILLION) 177
TABLE 149 UK: REVENUE CYCLE MANAGEMENT MARKET FOR INPATIENT FACILITIES, BY TYPE, 2021–2028 (USD MILLION) 177
TABLE 150 UK: REVENUE CYCLE MANAGEMENT MARKET FOR OUTPATIENT FACILITIES, BY TYPE, 2021–2028 (USD MILLION) 178
10.3.4 ITALY 178
10.3.4.1 Initiatives toward digitalizing patient records to drive market 178
TABLE 151 ITALY: KEY MACRO INDICATORS 179
TABLE 152 ITALY: REVENUE CYCLE MANAGEMENT MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 179
TABLE 153 ITALY: REVENUE CYCLE MANAGEMENT SOLUTIONS MARKET, BY TYPE, 2021–2028 (USD MILLION) 179
TABLE 154 ITALY: PATIENT ACCESS SOLUTIONS MARKET, BY TYPE, 2021–2028 (USD MILLION) 180
TABLE 155 ITALY: MID-REVENUE CYCLE SOLUTIONS MARKET, BY TYPE, 2021–2028 (USD MILLION) 180
TABLE 156 ITALY: BACK-END REVENUE CYCLE SOLUTIONS MARKET, BY TYPE, 2021–2028 (USD MILLION) 181
TABLE 157 ITALY: REVENUE CYCLE OUTSOURCING SERVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 181
TABLE 158 ITALY: REVENUE CYCLE MANAGEMENT MARKET, BY END USER, 2021–2028 (USD MILLION) 181
TABLE 159 ITALY: REVENUE CYCLE MANAGEMENT MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2021–2028 (USD MILLION) 182
TABLE 160 ITALY: REVENUE CYCLE MANAGEMENT MARKET FOR INPATIENT FACILITIES, BY TYPE, 2021–2028 (USD MILLION) 182
TABLE 161 ITALY: REVENUE CYCLE MANAGEMENT MARKET FOR OUTPATIENT FACILITIES, BY TYPE, 2021–2028 (USD MILLION) 183
10.3.5 SPAIN 183
10.3.5.1 IT infrastructural improvements to boost market 183
TABLE 162 SPAIN: KEY MACRO INDICATORS 184
TABLE 163 SPAIN: REVENUE CYCLE MANAGEMENT MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 184
TABLE 164 SPAIN: REVENUE CYCLE MANAGEMENT SOLUTIONS MARKET, BY TYPE, 2021–2028 (USD MILLION) 184
TABLE 165 SPAIN: PATIENT ACCESS SOLUTIONS MARKET, BY TYPE, 2021–2028 (USD MILLION) 185
TABLE 166 SPAIN: MID-REVENUE CYCLE SOLUTIONS MARKET, BY TYPE, 2021–2028 (USD MILLION) 185
TABLE 167 SPAIN: BACK-END REVENUE CYCLE SOLUTIONS MARKET, BY TYPE, 2021–2028 (USD MILLION) 186
TABLE 168 SPAIN: REVENUE CYCLE OUTSOURCING SERVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 186
TABLE 169 SPAIN: REVENUE CYCLE MANAGEMENT MARKET, BY DELIVERY MODE, 2021–2028 (USD MILLION) 187
TABLE 170 SPAIN: REVENUE CYCLE MANAGEMENT MARKET, BY END USER, 2021–2028 (USD MILLION) 187
TABLE 171 SPAIN: REVENUE CYCLE MANAGEMENT MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2021–2028 (USD MILLION) 187
TABLE 172 SPAIN: REVENUE CYCLE MANAGEMENT MARKET FOR INPATIENT FACILITIES, BY TYPE, 2021–2028 (USD MILLION) 188
TABLE 173 SPAIN: REVENUE CYCLE MANAGEMENT MARKET FOR OUTPATIENT FACILITIES, BY TYPE, 2021–2028 (USD MILLION) 188
10.3.6 REST OF EUROPE 188
TABLE 174 REST OF EUROPE: REVENUE CYCLE MANAGEMENT MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 189
TABLE 175 REST OF EUROPE: REVENUE CYCLE MANAGEMENT SOLUTIONS MARKET, BY TYPE, 2021–2028 (USD MILLION) 189
TABLE 176 REST OF EUROPE: PATIENT ACCESS SOLUTIONS MARKET, BY TYPE, 2021–2028 (USD MILLION) 190
TABLE 177 REST OF EUROPE: MID-REVENUE CYCLE SOLUTIONS MARKET, BY TYPE, 2021–2028 (USD MILLION) 190
TABLE 178 REST OF EUROPE: BACK-END REVENUE CYCLE SOLUTIONS MARKET, BY TYPE, 2021–2028 (USD MILLION) 191
TABLE 179 REST OF EUROPE: REVENUE CYCLE OUTSOURCING SERVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 191
TABLE 180 REST OF EUROPE: REVENUE CYCLE MANAGEMENT MARKET, BY DELIVERY MODE, 2021–2028 (USD MILLION) 192
TABLE 181 REST OF EUROPE: REVENUE CYCLE MANAGEMENT MARKET, BY END USER, 2021–2028 (USD MILLION) 192
TABLE 182 REST OF EUROPE: REVENUE CYCLE MANAGEMENT MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2021–2028 (USD MILLION) 192
TABLE 183 REST OF EUROPE: REVENUE CYCLE MANAGEMENT MARKET FOR INPATIENT FACILITIES, BY TYPE, 2021–2028 (USD MILLION) 193
TABLE 184 REST OF EUROPE: REVENUE CYCLE MANAGEMENT MARKET FOR OUTPATIENT FACILITIES, BY TYPE, 2021–2028 (USD MILLION) 193
10.4 ASIA PACIFIC 193
FIGURE 27 ASIA PACIFIC: REVENUE CYCLE MANAGEMENT MARKET SNAPSHOT 194
TABLE 185 ASIA PACIFIC: REVENUE CYCLE MANAGEMENT MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 195
TABLE 186 ASIA PACIFIC: REVENUE CYCLE MANAGEMENT MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 195
TABLE 187 ASIA PACIFIC: REVENUE CYCLE MANAGEMENT SOLUTIONS MARKET, BY TYPE, 2021–2028 (USD MILLION) 196
TABLE 188 ASIA PACIFIC: PATIENT ACCESS SOLUTIONS MARKET, BY TYPE, 2021–2028 (USD MILLION) 196
TABLE 189 ASIA PACIFIC: MID-REVENUE CYCLE SOLUTIONS MARKET, BY TYPE, 2021–2028 (USD MILLION) 197
TABLE 190 ASIA PACIFIC: BACK-END REVENUE CYCLE SOLUTIONS MARKET, BY TYPE, 2021–2028 (USD MILLION) 197
TABLE 191 ASIA PACIFIC: REVENUE CYCLE OUTSOURCING SERVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 198
TABLE 192 ASIA PACIFIC: REVENUE CYCLE MANAGEMENT MARKET, BY DELIVERY MODE, 2021–2028 (USD MILLION) 198
TABLE 193 ASIA PACIFIC: REVENUE CYCLE MANAGEMENT MARKET, BY END USER, 2021–2028 (USD MILLION) 198
TABLE 194 ASIA PACIFIC: REVENUE CYCLE MANAGEMENT MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2021–2028 (USD MILLION) 199
TABLE 195 ASIA PACIFIC: REVENUE CYCLE MANAGEMENT MARKET FOR INPATIENT FACILITIES, BY TYPE, 2021–2028 (USD MILLION) 199
TABLE 196 ASIA PACIFIC: REVENUE CYCLE MANAGEMENT MARKET FOR OUTPATIENT FACILITIES, BY TYPE, 2021–2028 (USD MILLION) 200
10.4.1 JAPAN 200
10.4.1.1 Government mandates to boost adoption of RCM solutions 200
TABLE 197 JAPAN: KEY MACRO INDICATORS 201
TABLE 198 JAPAN: REVENUE CYCLE MANAGEMENT MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 201
TABLE 199 JAPAN: REVENUE CYCLE MANAGEMENT SOLUTIONS MARKET, BY TYPE, 2021–2028 (USD MILLION) 201
TABLE 200 JAPAN: PATIENT ACCESS SOLUTIONS MARKET, BY TYPE, 2021–2028 (USD MILLION) 202
TABLE 201 JAPAN: MID-REVENUE CYCLE SOLUTIONS MARKET, BY TYPE, 2021–2028 (USD MILLION) 202
TABLE 202 JAPAN: BACK-END REVENUE CYCLE SOLUTIONS MARKET, BY TYPE, 2021–2028 (USD MILLION) 203
TABLE 203 JAPAN: REVENUE CYCLE OUTSOURCING SERVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 203
TABLE 204 JAPAN: REVENUE CYCLE MANAGEMENT MARKET, BY DELIVERY MODE, 2021–2028 (USD MILLION) 204
TABLE 205 JAPAN: REVENUE CYCLE MANAGEMENT MARKET, BY END USER, 2021–2028 (USD MILLION) 204
TABLE 206 JAPAN: REVENUE CYCLE MANAGEMENT MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2021–2028 (USD MILLION) 204
TABLE 207 JAPAN: REVENUE CYCLE MANAGEMENT MARKET FOR INPATIENT FACILITIES, BY TYPE, 2021–2028 (USD MILLION) 205
TABLE 208 JAPAN: REVENUE CYCLE MANAGEMENT MARKET FOR OUTPATIENT FACILITIES, BY TYPE 2021–2028 (USD MILLION) 205
10.4.2 CHINA 205
10.4.2.1 Digitalization and improving infrastructure to support market growth 205
TABLE 209 CHINA: KEY MACRO INDICATORS 206
TABLE 210 CHINA: REVENUE CYCLE MANAGEMENT MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 206
TABLE 211 CHINA: REVENUE CYCLE MANAGEMENT SOLUTIONS MARKET, BY TYPE, 2021–2028 (USD MILLION) 207
TABLE 212 CHINA: PATIENT ACCESS SOLUTIONS MARKET, BY TYPE, 2021–2028 (USD MILLION) 207
TABLE 213 CHINA: MID-REVENUE CYCLE SOLUTIONS MARKET, BY TYPE, 2021–2028 (USD MILLION) 208
TABLE 214 CHINA: BACK-END REVENUE CYCLE SOLUTIONS MARKET, BY TYPE, 2021–2028 (USD MILLION) 208
TABLE 215 CHINA: REVENUE CYCLE OUTSOURCING SERVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 209
TABLE 216 CHINA: REVENUE CYCLE MANAGEMENT MARKET, BY DELIVERY MODE, 2021–2028 (USD MILLION) 209
TABLE 217 CHINA: REVENUE CYCLE MANAGEMENT MARKET, BY END USER, 2021–2028 (USD MILLION) 210
TABLE 218 CHINA: REVENUE CYCLE MANAGEMENT MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2021–2028 (USD MILLION) 210
TABLE 219 CHINA: REVENUE CYCLE MANAGEMENT MARKET FOR INPATIENT FACILITIES, BY TYPE, 2021–2028 (USD MILLION) 210
TABLE 220 CHINA: REVENUE CYCLE MANAGEMENT MARKET FOR OUTPATIENT FACILITIES, BY TYPE 2021–2028 (USD MILLION) 211
10.4.3 INDIA 211
10.4.3.1 Growing patient pool to support market growth 211
TABLE 221 INDIA: KEY MACRO INDICATORS 212
TABLE 222 INDIA: REVENUE CYCLE MANAGEMENT MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 212
TABLE 223 INDIA: REVENUE CYCLE MANAGEMENT SOLUTIONS MARKET, BY TYPE, 2021–2028 (USD MILLION) 212
TABLE 224 INDIA: PATIENT ACCESS SOLUTIONS MARKET, BY TYPE, 2021–2028 (USD MILLION) 213
TABLE 225 INDIA: MID-REVENUE CYCLE SOLUTIONS MARKET, BY TYPE, 2021–2028 (USD MILLION) 213
TABLE 226 INDIA: BACK-END REVENUE CYCLE SOLUTIONS MARKET, BY TYPE, 2021–2028 (USD MILLION) 214
TABLE 227 INDIA: REVENUE CYCLE OUTSOURCING SERVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 214
TABLE 228 INDIA: REVENUE CYCLE MANAGEMENT MARKET, BY DELIVERY MODE, 2021–2028 (USD MILLION) 215
TABLE 229 INDIA: REVENUE CYCLE MANAGEMENT MARKET, BY END USER, 2021–2028 (USD MILLION) 215
TABLE 230 INDIA: REVENUE CYCLE MANAGEMENT MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2021–2028 (USD MILLION) 216
TABLE 231 INDIA: REVENUE CYCLE MANAGEMENT MARKET FOR INPATIENT FACILITIES, BY TYPE, 2021–2028 (USD MILLION) 216
TABLE 232 INDIA: REVENUE CYCLE MANAGEMENT MARKET FOR OUTPATIENT FACILITIES, BY TYPE 2021–2028 (USD MILLION) 217
10.4.4 REST OF ASIA PACIFIC 217
TABLE 233 REST OF ASIA PACIFIC: REVENUE CYCLE MANAGEMENT MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 218
TABLE 234 REST OF ASIA PACIFIC: REVENUE CYCLE MANAGEMENT SOLUTIONS MARKET, BY TYPE, 2021–2028 (USD MILLION) 218
TABLE 235 REST OF ASIA PACIFIC: PATIENT ACCESS SOLUTIONS MARKET, BY TYPE, 2021–2028 (USD MILLION) 219
TABLE 236 REST OF ASIA PACIFIC: MID-REVENUE CYCLE SOLUTIONS MARKET, BY TYPE, 2021–2028 (USD MILLION) 219
TABLE 237 REST OF ASIA PACIFIC: BACK-END REVENUE CYCLE SOLUTIONS MARKET, BY TYPE, 2021–2028 (USD MILLION) 220
TABLE 238 REST OF ASIA PACIFIC: REVENUE CYCLE OUTSOURCING SERVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 220
TABLE 239 REST OF ASIA PACIFIC: REVENUE CYCLE MANAGEMENT MARKET, BY DELIVERY MODE, 2021–2028 (USD MILLION) 221
TABLE 240 REST OF ASIA PACIFIC: REVENUE CYCLE MANAGEMENT MARKET, BY END USER, 2021–2028 (USD MILLION) 221
TABLE 241 REST OF ASIA PACIFIC: REVENUE CYCLE MANAGEMENT MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2021–2028 (USD MILLION) 221
TABLE 242 REST OF ASIA PACIFIC: REVENUE CYCLE MANAGEMENT MARKET FOR INPATIENT FACILITIES, BY TYPE, 2021–2028 (USD MILLION) 222
TABLE 243 REST OF ASIA PACIFIC: REVENUE CYCLE MANAGEMENT MARKET FOR OUTPATIENT FACILITIES, BY TYPE, 2021–2028 (USD MILLION) 222
10.5 LATIN AMERICA 222
10.5.1 HEALTHCARE INFRASTRUCTURAL DEVELOPMENTS TO SUPPORT MARKET GROWTH 222
TABLE 244 LATIN AMERICA: REVENUE CYCLE MANAGEMENT MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 223
TABLE 245 LATIN AMERICA: REVENUE CYCLE MANAGEMENT SOLUTIONS MARKET, BY TYPE, 2021–2028 (USD MILLION) 224
TABLE 246 LATIN AMERICA: PATIENT ACCESS SOLUTIONS MARKET, BY TYPE, 2021–2028 (USD MILLION) 224
TABLE 247 LATIN AMERICA: MID-REVENUE CYCLE SOLUTIONS MARKET, BY TYPE, 2021–2028 (USD MILLION) 225
TABLE 248 LATIN AMERICA: BACK-END REVENUE CYCLE SOLUTIONS MARKET, BY TYPE, 2021–2028 (USD MILLION) 225
TABLE 249 LATIN AMERICA: REVENUE CYCLE OUTSOURCING SERVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 226
TABLE 250 LATIN AMERICA: REVENUE CYCLE MANAGEMENT MARKET, BY DELIVERY MODE, 2021–2028 (USD MILLION) 226
TABLE 251 LATIN AMERICA: REVENUE CYCLE MANAGEMENT MARKET, BY END USER, 2021–2028 (USD MILLION) 227
TABLE 252 LATIN AMERICA: REVENUE CYCLE MANAGEMENT MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2021–2028 (USD MILLION) 227
TABLE 253 LATIN AMERICA: REVENUE CYCLE MANAGEMENT MARKET FOR INPATIENT FACILITIES, BY TYPE, 2021–2028 (USD MILLION) 227
TABLE 254 LATIN AMERICA: REVENUE CYCLE MANAGEMENT MARKET FOR OUTPATIENT FACILITIES, BY TYPE, 2021–2028 (USD MILLION) 228
10.6 MIDDLE EAST & AFRICA 228
10.6.1 GOVERNMENT FUNDING & INITIATIVES TO SUPPORT MARKET GROWTH 228
TABLE 255 MIDDLE EAST & AFRICA: REVENUE CYCLE MANAGEMENT MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 229
TABLE 256 MIDDLE EAST & AFRICA: REVENUE CYCLE MANAGEMENT SOLUTIONS MARKET, BY TYPE, 2021–2028 (USD MILLION) 229
TABLE 257 MIDDLE EAST & AFRICA: PATIENT ACCESS SOLUTIONS MARKET, BY TYPE, 2021–2028 (USD MILLION) 230
TABLE 258 MIDDLE EAST & AFRICA: MID-REVENUE CYCLE SOLUTIONS MARKET, BY TYPE, 2021–2028 (USD MILLION) 230
TABLE 259 MIDDLE EAST & AFRICA: BACK-END REVENUE CYCLE SOLUTIONS MARKET, BY TYPE, 2021–2028 (USD MILLION) 231
TABLE 260 MIDDLE EAST & AFRICA: REVENUE CYCLE OUTSOURCING SERVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 231
TABLE 261 MIDDLE EAST & AFRICA: REVENUE CYCLE MANAGEMENT MARKET, BY DELIVERY MODE, 2021–2028 (USD MILLION) 232
TABLE 262 MIDDLE EAST & AFRICA: REVENUE CYCLE MANAGEMENT MARKET, BY END USER, 2021–2028 (USD MILLION) 232
TABLE 263 MIDDLE EAST & AFRICA: REVENUE CYCLE MANAGEMENT MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2021–2028 (USD MILLION) 232
TABLE 264 MIDDLE EAST & AFRICA: REVENUE CYCLE MANAGEMENT MARKET FOR INPATIENT FACILITIES, BY TYPE, 2021–2028 (USD MILLION) 233
TABLE 265 MIDDLE EAST & AFRICA: REVENUE CYCLE MANAGEMENT MARKET FOR OUTPATIENT FACILITIES, BY TYPE, 2021–2028 (USD MILLION) 233
11 COMPETITIVE LANDSCAPE 234
11.1 OVERVIEW 234
FIGURE 28 KEY DEVELOPMENTS OF MAJOR PLAYERS BETWEEN JANUARY 2020 AND JUNE 2023 235
11.2 MARKET RANKING ANALYSIS 236
FIGURE 29 REVENUE CYCLE MANAGEMENT, BY PLAYER, 2022 236
11.3 REVENUE SHARE ANALYSIS OF TOP MARKET PLAYERS 236
FIGURE 30 REVENUE CYCLE MANAGEMENT: REVENUE ANALYSIS OF KEY PLAYERS 236
11.4 REVENUE CYCLE MANAGEMENT MARKET: R&D EXPENDITURE 237
FIGURE 31 R&D EXPENDITURE OF KEY PLAYERS (2021 VS. 2022) 237
11.5 COMPETITIVE BENCHMARKING 237
TABLE 266 COMPANY FOOTPRINT ANALYSIS 237
TABLE 267 COMPANY PRODUCT AND SERVICES FOOTPRINT 238
TABLE 268 COMPANY END USER FOOTPRINT 239
TABLE 269 COMPANY REGIONAL FOOTPRINT 240
11.6 COMPANY EVALUATION MATRIX 241
11.6.1 STARS 241
11.6.2 EMERGING LEADERS 241
11.6.3 PERVASIVE PLAYERS 241
11.6.4 PARTICIPANTS 242
FIGURE 32 REVENUE CYCLE MANAGEMENT MARKET: COMPANY EVALUATION MATRIX (2022) 242
11.7 COMPANY EVALUATION MATRIX FOR START-UPS/SMES 243
11.7.1 PROGRESSIVE COMPANIES 243
11.7.2 DYNAMIC COMPANIES 243
11.7.3 RESPONSIVE COMPANIES 243
11.7.4 STARTING BLOCKS 243
FIGURE 33 REVENUE CYCLE MANAGEMENT: COMPANY EVALUATION MATRIX FOR START-UPS/SMES (2022) 244
11.8 COMPETITIVE SCENARIO 245
11.8.1 PRODUCT LAUNCHES 245
TABLE 270 PRODUCT LAUNCHES, JANUARY 2020–JUNE 2023 245
11.8.2 DEALS 246
TABLE 271 DEALS, JANUARY 2020–MAY 2023 246
12 COMPANY PROFILES 247
(Business Overview, Products Offered, Recent Developments, MnM View Right to win, Strategic choices made, Weaknesses and competitive threats) *
12.1 KEY PLAYERS 247
12.1.1 OPTUM, INC. 247
TABLE 272 OPTUM, INC.: BUSINESS OVERVIEW 247
FIGURE 34 OPTUM, INC.: COMPANY SNAPSHOT (2022) 248
12.1.2 R1 RCM, INC. 252
TABLE 273 R1 RCM, INC.: BUSINESS OVERVIEW 252
12.1.3 ORACLE 258
TABLE 274 ORACLE: BUSINESS OVERVIEW 258
FIGURE 35 ORACLE: COMPANY SNAPSHOT (2022) 259
12.1.4 CHANGE HEALTHCARE 263
TABLE 275 CHANGE HEALTHCARE: BUSINESS OVERVIEW 263
FIGURE 36 CHANGE HEALTHCARE: COMPANY SNAPSHOT (2022) 263
12.1.5 MCKESSON CORPORATION 269
TABLE 276 MCKESSON CORPORATION: BUSINESS OVERVIEW 269
FIGURE 37 MCKESSON CORPORATION: COMPANY SNAPSHOT (2022) 270
12.1.6 3M 273
TABLE 277 3M: BUSINESS OVERVIEW 273
FIGURE 38 3M: COMPANY SNAPSHOT (2022) 274
12.1.7 EXPERIAN PLC 277
TABLE 278 EXPERIAN PLC: BUSINESS OVERVIEW 277
FIGURE 39 EXPERIAN PLC: COMPANY SNAPSHOT (2022) 278
12.1.8 CONIFER HEALTH SOLUTIONS, LLC 281
TABLE 279 CONIFER HEALTH SOLUTIONS, LLC: BUSINESS OVERVIEW 281
FIGURE 40 CONIFER HEALTH SOLUTIONS, LLC: COMPANY SNAPSHOT (2022) 281
12.1.9 VERADIGM LLC 284
TABLE 280 VERADIGM LLC: BUSINESS OVERVIEW 284
FIGURE 41 VERADIGM LLC: COMPANY SNAPSHOT (2021) 284
12.1.10 GE HEALTHCARE 288
TABLE 281 GE HEALTHCARE: BUSINESS OVERVIEW 288
FIGURE 42 GE HEALTHCARE: COMPANY SNAPSHOT (2022) 289
12.1.11 COGNIZANT 291
TABLE 282 COGNIZANT: BUSINESS OVERVIEW 291
FIGURE 43 COGNIZANT: COMPANY SNAPSHOT (2022) 292
12.1.12 ATHENAHEALTH, INC. 295
TABLE 283 ATHENAHEALTH: BUSINESS OVERVIEW 295
12.1.13 THE SSI GROUP, LLC 301
TABLE 284 THE SSI GROUP, LLC: BUSINESS OVERVIEW 301
12.1.14 ADVANTEDGE HEALTHCARE SOLUTIONS 303
TABLE 285 ADVANTEDGE HEALTHCARE SOLUTIONS: BUSINESS OVERVIEW 303
12.1.15 HURON CONSULTING GROUP INC. 305
TABLE 286 HURON CONSULTING GROUP INC.: BUSINESS OVERVIEW 305
FIGURE 44 HURON CONSULTING GROUP INC.: COMPANY SNAPSHOT (2022) 305
12.1.16 FINTHRIVE 308
TABLE 287 FINTHRIVE: BUSINESS OVERVIEW 308
12.1.17 PLUTUS HEALTH 311
TABLE 288 PLUTUS HEALTH: BUSINESS OVERVIEW 311
12.1.18 QUEST DIAGNOSTICS INCORPORATED 313
TABLE 289 QUEST DIAGNOSTICS INCORPORATED: BUSINESS OVERVIEW 313
FIGURE 45 QUEST DIAGNOSTICS INCORPORATED: COMPANY SNAPSHOT (2022) 313
12.1.19 GEBBS 315
TABLE 290 GEBBS: BUSINESS OVERVIEW 315
12.1.20 EPIC SYSTEMS CORPORATION 317
TABLE 291 EPIC SYSTEMS CORPORATION: BUSINESS OVERVIEW 317
12.2 OTHER PLAYERS 318
12.2.1 OMEGA HEALTHCARE 318
12.2.2 TRUBRIDGE 319
12.2.3 CARECLOUD, INC. 320
12.2.4 CONSTELLATION SOFTWARE INC. 321
12.2.5 VEE TECHNOLOGIES 322
*Details on Business Overview, Products Offered, Recent Developments, MnM View, Right to win, Strategic choices made, Weaknesses and competitive threats might not be captured in case of unlisted companies.
13 APPENDIX 323
13.1 INSIGHTS FROM INDUSTRY EXPERTS 323
13.2 DISCUSSION GUIDE 324
13.3 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 328
13.4 CUSTOMIZATION OPTIONS 330
13.5 RELATED REPORTS 330
13.6 AUTHOR DETAILS 331